US Supreme Court Won’t Hear Risperdal Appeal

Washington, DC: The United States Supreme Court has decided it will not hear Johnson & Johnson’s appeal of a $124 million judgment against it in a Risperdal lawsuit. The lawsuit was filed by the state of South Carolina, alleging Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals illegally marketed its antipsychotic medication.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s